George Magrath
Director Ejecutivo en OCUPHIRE PHARMA, INC. .
Fortuna: 660 050 $ al 30/04/2024
Perfil
George Magrath is currently the Chief Executive Officer & Director at Ocuphire Pharma, Inc. He was previously the Chief Executive Officer & Director at Lexitas Pharma Services, Inc. from 2021 to 2023.
Prior to that, he worked as an Analyst at Edison Investment Research, Inc. Dr. Magrath holds a doctorate degree from the Medical University of South Carolina, an MBA from The Citadel, The Military College of South Carolina, an undergraduate degree from Clemson University, and a graduate degree from The Johns Hopkins University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
OCUPHIRE PHARMA, INC.
1.73% | 17/05/2024 | 430 000 ( 1.73% ) | 660 050 $ | 30/04/2024 |
Cargos activos de George Magrath
| Empresas | Cargo | Inicio |
|---|---|---|
| OCUPHIRE PHARMA, INC. | Director Ejecutivo | 01/11/2023 |
Antiguos cargos conocidos de George Magrath.
| Empresas | Cargo | Fin |
|---|---|---|
Lexitas Pharma Services , Inc.
 Lexitas Pharma Services , Inc. Medical/Nursing ServicesHealth Services Lexitas Pharma Services, Inc. is a product development organization that specializes in delivering life-changing ophthalmic treatments to patients. The company is based in Durham, NC and was founded in 2011 by Saiid Davari, Joanna Williams, Chad Ice, Chris Brown. The company's team of skilled specialists, relationship builders, and ophthalmic experts have a wealth of expertise gained from years of running successful eye care studies. The company offers personalized services and end-to-end expert guidance to optimize study execution and design programs around specific study requirements. The CEO is George Magrath. | Director Ejecutivo | 30/09/2023 |
Edison Investment Research, Inc.
 Edison Investment Research, Inc. Investment ManagersFinance Edison Investment Research, Inc. is an investment research firm located in New York City. The firm is a subsidiary of Edison Investment Research Ltd., a leading international investment research firm. The firm writes on more than 350 companies across every sector and works directly with corporates, fund managers, investment banks, brokers and other advisers. Edison's research is read by institutional investors, alternative funds and wealth managers in more than 100 countries. | Analyst-Equity | - |
Formación de George Magrath.
| Medical University of South Carolina | Doctorate Degree |
| The Citadel, The Military College of South Carolina | Masters Business Admin |
| Clemson University | Undergraduate Degree |
| The Johns Hopkins University | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| OCUPHIRE PHARMA, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Edison Investment Research, Inc.
Edison Investment Research, Inc. Investment ManagersFinance Edison Investment Research, Inc. is an investment research firm located in New York City. The firm is a subsidiary of Edison Investment Research Ltd., a leading international investment research firm. The firm writes on more than 350 companies across every sector and works directly with corporates, fund managers, investment banks, brokers and other advisers. Edison's research is read by institutional investors, alternative funds and wealth managers in more than 100 countries. | Finance |
Lexitas Pharma Services , Inc.
Lexitas Pharma Services , Inc. Medical/Nursing ServicesHealth Services Lexitas Pharma Services, Inc. is a product development organization that specializes in delivering life-changing ophthalmic treatments to patients. The company is based in Durham, NC and was founded in 2011 by Saiid Davari, Joanna Williams, Chad Ice, Chris Brown. The company's team of skilled specialists, relationship builders, and ophthalmic experts have a wealth of expertise gained from years of running successful eye care studies. The company offers personalized services and end-to-end expert guidance to optimize study execution and design programs around specific study requirements. The CEO is George Magrath. | Health Services |
- Bolsa de valores
- Insiders
- George Magrath
